IPC provides clinicians with resources and training to best manage their psoriasis patients and conducts research into the disease to improve care worldwide.
IPC is heading to Vienna for #EADV2026! The session will cover molecular and clinical insights into treatment response, therapeutic drug monitoring, and dose optimization, with short expert talks followed by open discussion.
https://t.co/ttVn6P8Kmv
#PsoriasisEvent#Psoriasis
#IPCJrCouncilors Maria Julia Cura and Jennifer Lavina Ngo summarize six presentations from the IPC symposium at #SID2026, covering disease interception, immune memory, molecular profiling, oral versus biologic approaches, and more.
https://t.co/3j6NFPHOuh
#IPCJrCouncilor Mio Nakamura examines how personality traits can influence trust, communication, and the doctor-patient relationship in dermatology. She offers practical guidance on adapting your approach without crossing clinical boundaries.
https://t.co/1tk02fUI3j
🔁#AAD2026 delivered late-breaking research, emerging therapies, & new clinical insights. Explore IPC's coverage, including the IEC & IPC Joint Symposium & key psoriasis sessions, summarized by #IPCJrCouncilors Maria-Angeliki Gkini & Josep Riera-Monroig: https://t.co/TpRSj1nn8t
Videos from the IPC & IEC Joint Symposium at the 2026 American Academy of Dermatology (AAD) Annual Meeting are now on the IPC website.
Watch the recordings: https://t.co/3Z8BYxwvqI
#PsoriasisEducation#Psoriasis#AtopicDermatitis@CouncilEczema
📰 The May edition of the IPC Psoriasis Review is here!
Join 12,000+ dermatology professionals who rely on IPC for updates on psoriasis research, education, and clinical care.
Read the May issue now: https://t.co/GSFrPqWEYS
#PsoriasisNews#IPCNews#Psoriasis
#IPC and @CouncilEczema (#IEC) will co-host the Eczema and Psoriasis Research Incubator #ESDR2026. The program will bring together inflammatory skin disease researchers for expert-led discussions, collaboration, networking, and new research partnerships: https://t.co/fMNEdOgP0t
Last week, IPC welcomed the inaugural group of #IPCJrCouncilors — Fellowship Program alumni taking on a more active role in IPC through education, collaboration, and psoriasis-focused initiatives.
Meet the current Jr. Councilors: https://t.co/UkTsSrLh7w
The @ILDSDerm will host a webinar on May 29 from 12:00–13:00 GMT on Artificial Intelligence in Dermatology.The session will discuss the opportunities and limitations of AI in dermatology, including implications for clinicians and societies.
Learn more: https://t.co/2ohfM6daUS
In this Take Ten, Prof Peter van de Kerkhof discusses topical corticosteroid treatment in psoriasis, including current approaches, guideline recommendations, and potential consequences of long-term use.
https://t.co/YfwhmtmgA6
#Psoriasis#Dermatology#TopicalTreatment
ICYMI: A new regional collaboration has been announced to improve care for #psoriasis and psoriatic arthritis across Latin America, bringing together IPC, @PsoriasisIFPA, PANLAR, SOLAPSO, and COLAPPIEL.
Read the full announcement: https://t.co/nx8BME2780
🔁 IPC's latest summary slide provides a practical, clinic-ready framework for assessing disease severity and guiding treatment escalation. Designed as a quick reference, it helps clinicians apply IPC's classification to inform therapy decisions. Download: https://t.co/IxrUAW5jK2
🔁 Dr. Mari Løset and Dr. Maxwell Sauder join IPC's global network, bringing expertise in translational research, data science, and oncodermatology. Their work strengthens IPC's data-driven, evidence-based approach and expands its presence to Norway.
https://t.co/JlSqw433hV
At the IPC Think Tank, 2025 Fellows were welcomed as #IPCJrCouncilors, marking the completion of their fellowship. Congrats to Malin Assarsson, Nicholas Brownstone, Dina ElDisouki, Jennifer Ngo, Ravi Ramessur, Doriane Sabushimike, & Ralph da Rosa: https://t.co/8XWoosYPE3
Thank you to everyone who joined the IPC, SOLAPSO, & SOARPSO Educational Partnership Symposium at #RADLA2026! Thanks to our co-chairs, faculty, & partner orgs for bringing together important regional perspectives and discussions relevant to clinical practice across Latin America.
ICYMI: #IPCCouncilor Matias Maskin reviews findings from BADBIR, discussing the impact of first-line biologics on long-term outcomes, faster clearance, and reduced comorbidity risk, and what delayed access may cost patients.
https://t.co/AIRkQCX5Ji
#Psoriasis#Biologics
🔁#AAD2026 delivered late-breaking research, emerging therapies, & new clinical insights. Explore IPC's coverage, including the IEC & IPC Joint Symposium & key psoriasis sessions, summarized by #IPCJrCouncilors Maria-Angeliki Gkini & Josep Riera-Monroig: https://t.co/TpRSj1nn8t
In recognition of World Hypertension Day, revisit this video from #IPCCouncilor Dr. Álvaro González-Cantero on psoriasis as an independent risk factor for cardiovascular disease.
Watch the full video: https://t.co/QuKW2R1KCM
#Psoriasis#Hypertension#PsoriasisComorbidities